genedrive plc (LON:GDR – Get Free Report) insider Gino Miele acquired 700,000 shares of the business’s stock in a transaction dated Friday, August 28th. The stock was bought at an average cost of GBX 1 per share, with a total value of £7,000.
genedrive Price Performance
LON:GDR opened at GBX 1.47 on Tuesday. The stock has a market capitalization of £23.60 million, a PE ratio of -1.86 and a beta of 0.99. genedrive plc has a 1-year low of GBX 0.19 and a 1-year high of GBX 1.55. The firm has a fifty day simple moving average of GBX 1.21 and a 200 day simple moving average of GBX 1.12. The company has a current ratio of 0.99, a quick ratio of 5.52 and a debt-to-equity ratio of -120.48.
genedrive Company Profile
genedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms. Based in the UK, the Company is at the forefront of Point of Care pharmacogenetic testing in emergency healthcare.
Featured Stories
- Five stocks we like better than genedrive
- Securing AI: 5 Most-Upgraded Stocks From the Q2 Reporting Season
- Insiders Are Betting Big on These 3 Healthcare Stocks
- 3 Stocks for Investors Who Still Believe Cash Is King
- Dollar General and Dollar Tree Are Recovering, But Not for the Same Reason
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.
